Get the StoQuant digest — free

Daily Q-Score changes, insider buy clusters, and ML forecast updates for the tickers you follow. Email only, no account needed. See a sample digest.

Agios Pharmaceuticals, Inc. (AGIO) — Quantitative Stock Analysis

Quantitative analysis for Agios Pharmaceuticals, Inc. (AGIO) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based return forecast, technical and fundamental signals, insider and institutional flow, and walk-forward validated accuracy.

Current Q-Score verdict: Buy (57.0) (grade B). Gem alpha score: 55.0. 30 signals analyzed (24 differentiated alt-data).

Key Quantitative Facts

Compare AGIO against Health Care peers

What StoQuant measures for AGIO

Access the full research

Detailed interactive charts, factor decomposition, and forecast bands are available to signed-in members. Learn more or view pricing.

Get AGIO's Q-Score in your inbox — free

Join the free StoQuant digest: daily Q-Score changes, insider flow, and forecast updates for AGIO and the market's most-watched tickers. No account needed — unsubscribe anytime. See a sample digest.

Embed StoQuant Q-Score Badge

Share this stock's Q-Score on your site or GitHub README with an embeddable SVG badge. Copy the snippet below:

<img src="https://stoquant.com/badge/AGIO.svg" alt="Agios Pharmaceuticals, Inc. (AGIO) Q-Score" width="240" height="64" />

The badge auto-updates with the latest Q-Score. View badge.